This is the authors' abstract. We don't add key points for this paper.
Seventeen human immunodeficiency virus-infected patients who were harboring untreated subclinical visceral leishmaniasis (VL) were prospectively followed up. None of the 11 patients who received highly active antiretroviral therapy (HAART) presented with symptomatic VL during follow-up, whereas 2 out of 6 patients who received therapy other than HAART had an episode of overt kala-azar. These findings suggest that HAART does not induce the evolution of latent VL into symptomatic disease.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Rosa et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: